T cell immunity and vaccines against invasive fungal diseases

Immunol Invest. 2011;40(7-8):825-38. doi: 10.3109/08820139.2011.595472. Epub 2011 Aug 4.


Over the past two decades much has been learned about the immunology of invasive fungal infection, especially invasive candidiasis and invasive aspergillosis. Although quite different in their pathogenesis, the major common protective host response is Th1 mediated. It is through Th1 cytokine production that the effector cells, phagocytes, are activated to kill the fungus. A more thorough understanding of the pathogenesis of disease, the elicited protective Th1 immune response, the T cell antigen(s) which elicit this response, and the mechanism(s) whereby one can enhance, reconstitute, or circumvent the immunosuppressed state will, hopefully, lead to the development of a vaccine(s) capable of protecting even the most immunocompromised of hosts.

Publication types

  • Review

MeSH terms

  • Animals
  • Aspergillosis / immunology*
  • Aspergillosis / microbiology
  • Aspergillosis / physiopathology
  • Aspergillus / immunology
  • Aspergillus / pathogenicity*
  • Candida / immunology
  • Candida / pathogenicity*
  • Candidiasis / immunology*
  • Candidiasis / microbiology
  • Candidiasis / physiopathology
  • Fungal Vaccines / immunology*
  • Humans
  • Immunity, Cellular
  • Mice
  • T-Lymphocytes / immunology*


  • Fungal Vaccines